Peer Review History
| Original SubmissionApril 23, 2021 |
|---|
|
PONE-D-21-13372 Neonatal mortality and Associated Factors among Neonates Admitted to Neonatal Intensive Care Unit in Public Hospitals of Somali Regional State, Eastern Ethiopia: A two years’ retrospective Analysis PLOS ONE Dear Dr. Abdurke Kure Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR: Your manuscript was reviewed by 3 experts in the field. The majority identified many important problems in your submission and provided copious comments. Please revise the manuscript as per the reviewers' comments especially the results section was difficult to follow. Please consider the reviewers' comments and provide point-by-point responses. Please upload the figures again. We have noticed that you did not upload your data, Plos one allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Please submit your revised manuscript by July 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ammal Mokhtar Metwally, Ph.D (MD) Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study, including: a) whether all data were fully anonymized before you accessed them; b) the date range (month and year) during which patients' medical records were accessed; c) the date range (month and year) during which patients whose medical records were selected for this study sought treatment. If the ethics committee waived the need for informed consent, or patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Thank you for stating the following in the Funding Section of your manuscript: [This study was funded by Jigjiga Universityand the Ethiopian Ministry of Science and Higher Education. The funding organizations had no role in the study design, data collection, data analysis, and writing up of the manuscript.] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to read your paper examining predictors and incidence of neonatal mortality in Eastern Ethiopia. I read your paper with interest and think examining these cohorts, especially in the developing world, is important. Generally, I believe the conclusions are fair, albeit limited by the cross-sectional design. My major comment is with respect to “Reviewer Question 4” which relates to clear, correct and unambiguous language, without typographical or grammatical errors. Generally, given multiple errors in syntax & frequent repetition, the manuscript is difficult to read and as such the specifics around methodology are difficult to follow. There are multiple paragraphs of information that could readily be condensed into 2-3 sentences. I have included some of my feedback below, but this is not all-encompassing as these errors are present throughout the manuscript. General comments: 1. A punchier title may be considered – perhaps revise to “Neonatal mortality and Associated Factors among Neonates Admitted to the Neonatal Intensive Care Unit in Eastern Ethiopia”. 2. In tables, precise p values should be stated instead of <0.25 or <0.05. 3. Figure 2 is likely unnecessary as it represents only a binary pie chart. 4. Generally, I’d suggest removing “died” and replacing with “mortality” where possible. Introduction 5. Line 23: Insert “a” between “remains” and “public health challenge” 6. Line 25-26: Suggest replace sentence with “In comparison with countries demonstrating the lowest neonatal mortality, the risk of mortality is over 30 times higher in Sub-Saharan Africa”. 7. Line 35-36 can be simplified to “identify the effect of predictors on mortality” 8. Abstract results – suggest include p values 9. Line 52-53 in which year? 2017? Consider rewording 10. Line 63 – neonatal mortality in India and Pakistan not relevant given not in Africa. Listing rates in these countries is not necessary in this sentence. Also, is this intended to be 38 / 1000 live births, or 38% of neonatal admissions? The sentence reads as all-cause neonatal mortality. 11. Line 72 change declined to decline and clarify “but not met national target” as this doesn’t read well & doesn’t make sense here. 12. Line 83-90 from editorial point of view try to delete some of the “for instance” and “for example” 13. The introduction is overall a bit wordy and repetitious and could be shortened. Methods 14. Need to define “Woredas” and “Kebeles” for international readers. 15. Line 109 – delete “and” 16. Line 114 – “woreda” is not capitalised as previously done. 17. Line 122 delete “and” The methods are particularly difficult to follow given multiple typographical and grammatical errors. I have listed only a few of them above and would suggest a thorough proof reading and rephrasing in many places for clarity. Results 18. Line 242 – replace “in” with of” 19. Again multiple typographical errors (including above) which should be proof read and corrected. Discussion The discussion revolves primarily around comparisons with mortality in other regions and countries. Line 289 – 315 is entirely dedicated to comparator cohorts, of which > 10 are listed. Consider abbreviating this list and condensing this to one paragraph discussing similar cohorts. Minor comments: 20. Line 294 – How is Turkey relevant here? Suggest removing. 21. Line 301-302 remove the assertion regarding difference due to time of the study and sample size as this is stated in the following sentence anyway. 22. Line 351 delete “Strengths of the study” and “Limitation of the study”. This section needs revising. Standardised checklists and questionnaires are not necessarily a strength. 23. Lines 352-354 is poorly worded. Conclusion Conclusions are appropriate but again need to be reworded for simplicity. While I think the results of this study are interesting and relevant to both the scientific community in Ethiopia and the international community, this paper requires major revision, primarily from a language point of view to reduce repetition, simplify the methodology for the reader, and reduce the burden of language errors. Reviewer #2: The authors studied predictors of neonatal mortality in 3 public hospitals in the Somali region, Eastern Ethiopia. The research is original, it was the first in this region which is mainly a rural area. The data presented supported the conclusion and fitted with the study objective. The sample size was calculated appropriately, the sample was randomly selected and the satatistical analysis were rigorously performed. The results were properly discussed and the limitations of the study were mentioned. However, I have some suggestions to improve the manuscripts : 1. There are some grammer and spelling mistakes 2. The p-value of the Hosmer-Lemeshow goodness of fitness test is a result and should be included with the table of the final model in the results section with the determination coefficient R2. 3. I suggest to present the final model only of the multivariable regression with the goodness of fit criteria. Reviewer #3: The article provides a very nice picture on neonatal mortality and relevant risk factors for neonatal mortality in Ethiopia. It is worthwhile to be published. However, the article is not written carefully, abbreviations are not introduced, and country specific situation are not explained for an international readership and one citation is misleading. General remarks: Abbreviation need to be introduced once when used first time, and then this abbreviation shall be used through the whole text. I believe NMR is introduce three times, however ANC, NM, and NICU is not explained at all. Due to the tremendous use of abbreviation, I also suggest providing an abbreviation list where all abbreviations are explained. Please check the correct use of all abbreviation in the text. Introduction: The introduction explains the importance of the research question and uses relevant literature. However, the rates from neonatal mortality seems to be wrong, (line 61 ff: information of neonatal mortality is normally given in number per 1000 and not in %; the relevant cited source is connected to under 5 years mortality which does not make sense in this context; and the numbers are not repeatable. Please correct these numbers and cite a correct source. Furthermore, I suggest introducing shortly the Apgar-score as well as ANC and ANC follow up in the introduction. You cannot expect that the international readership knows this words/abbreviations. Method: In the study population sample size, data collection and data analysis are presented carefully. However, the sample size calculation can be presented more condensed. And the coding of neonatal mortality can be dropped from the explanation. Furthermore, under analysis it was mentioned that collinearity analysis was done, but the results were not presented. I expect a high collinearity between apgar-score and asphyxia (which is defined via apgar score) and ANC follow up and No of ANC-visits. Therefore, the results are important to present. Result: Result presentation is nice and carefully done. As small remark to some tables: • Table 2:, I suggest to present for binary variables only one line. If you know that 8.6 (n=44) have Hypothermia, then it is implicitly given that the rest do not have hyperthermia this line can be dropped from the table. However, that is relevant only for binary/dichotomous variables. On the other hand, there is one variable (number of ANC visits) which is not dichotomous/binary, but only presented in this form, clarification is necessary. • Table 4: significant results are only marked under AOR but not under COR. Please add this. Furthermore, both abbreviations need to be introduced under the table. • Figure 1. The arrow text line “Simple random sampling (SRS)” can be dropped. The line above contains 196+178+140 which gives exactly 514. No random sampling took place at this stage of sampling procedure. • Figure 2 can be deleted, The results of this figure can be added in table 2 Discussion: The discussion is nicely done, good work. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Hedia Bellali Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-13372R1Neonatal mortality and Associated Factors among Neonates Admitted to Neonatal Intensive Care Unit in Public Hospitals of Somali Regional State, Eastern Ethiopia: A two years’ retrospective AnalysisPLOS ONE Dear Dr. Kure, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for your response to the reviewer comments. The reviewers consider the manuscript to be much improved. However, some additional editorial concerns must be addressed before the manuscript can be considered for publication. Specifically, we found a degree of text overlap between your submission and the following previously published works:
Please review the entire manuscript, especially the abovementioned sections to ensure that you rephrase any duplicated text and cite your sources in full. In addition, please review the manuscript again to check for any remaining typographical and grammatical errors, particularly in the Abstract. Thank you for your attention to these requests. Please submit your revised manuscript by Nov 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marianne Clemence Associate Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Significantly improved and have addressed most of my concerns. I would suggest one further review with a language editor as there are still a few syntax errors, and then after that to accept for publication. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr Hedia Bellali, Associate professor in Epidemiology and Public Health, Medical Faculty of Tunis, Tunisia [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Neonatal mortality and Associated Factors among Neonates Admitted to Neonatal Intensive Care Unit in Public Hospitals of Somali Regional State, Eastern Ethiopia: A multicenter retrospective Analysis PONE-D-21-13372R2 Dear Dr. Kure, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, George Vousden Deputy Editor-in-Chief PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have adressed all the reviewer's comments. However, the paper layout is still to be improved, there are some mistakes of presentation: spaces between references and text... ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Prof Hedia Bellali |
| Formally Accepted |
|
PONE-D-21-13372R2 Neonatal mortality and Associated Factors among Neonates Admitted to Neonatal Intensive Care Unit at Public Hospitals of Somali Regional State, Eastern Ethiopia: A multicenter retrospective Analysis Dear Dr. Kure: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. George Vousden Staff Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .